Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joshua P Lewis

Showing results (11-20 of 51) with videos related to

Pageof 6
Sort By:
Current Vascular Pharmacology|September 17, 2015
The Pharmacogenomics of Anti-Platelet Intervention (PAPI) Study: Variation in Platelet Response to Clopidogrel and AspirinLaura M Bozzi, Braxton D Mitchell, Joshua P Lewis, et al.
G3 (Bethesda, Md.)|September 9, 2016
Effect of Two Lipoprotein (a)-Associated Genetic Variants on Plasminogen Levels and FibrinolysisHong Wang, Chan E Hong, Joshua P Lewis, et al.
Clinical Pharmacology and Therapeutics|June 21, 2020
Genetic Variation in PEAR1, Cardiovascular Outcomes and Effects of Aspirin in a Healthy Elderly PopulationJoshua P Lewis, Moeen Riaz, Sophia Xie, et al.
Journal of Clinical Lipidology|December 17, 2018
Increased usual physical activity is associated with a blunting of the triglyceride response to a high-fat mealBraxton D Mitchell, Gurmannat Kalra, Kathleen A Ryan, et al.
The Journal of Clinical Endocrinology and Metabolism|October 26, 2006
Association of alpha2-Heremans-Schmid glycoprotein polymorphisms with subclinical atherosclerosisAllison B Lehtinen, Kathryn P Burdon, Joshua P Lewis, et al.
G3 (Bethesda, Md.)|July 15, 2016
From Genotype to Phenotype: Nonsense Variants in SLC13A1 Are Associated with Decreased Serum Sulfate and Increased Serum AminotransferasesChristina G Tise, James A Perry, Leslie E Anforth, et al.
Journal of the American Heart Association|May 29, 2015
CYP2C19 metabolizer status and clopidogrel efficacy in the Secondary Prevention of Small Subcortical Strokes (SPS3) studyCaitrin W McDonough, Leslie A McClure, Braxton D Mitchell, et al.
Pharmacogenetics and Genomics|February 17, 2017
Genome-wide analysis of clopidogrel active metabolite levels identifies novel variants that influence antiplatelet responseJoshua D Backman, Jeffrey R O'Connell, Keith Tanner, et al.
Plos One|September 26, 2015
Genetic Variation in the Platelet Endothelial Aggregation Receptor 1 Gene Results in Endothelial DysfunctionAdam S Fisch, Laura M Yerges-Armstrong, Joshua D Backman, et al.
Journal of the American Heart Association|October 28, 2015
Oxylipid Profile of Low-Dose Aspirin Exposure: A Pharmacometabolomics StudySandrine Ellero-Simatos, Amber L Beitelshees, Joshua P Lewis, et al.
Pageof 6

Showing results (11-20 of 51) with videos related to

Sort By:
Pageof 6
Current Vascular Pharmacology|September 17, 2015
The Pharmacogenomics of Anti-Platelet Intervention (PAPI) Study: Variation in Platelet Response to Clopidogrel and AspirinLaura M Bozzi, Braxton D Mitchell, Joshua P Lewis, et al.
G3 (Bethesda, Md.)|September 9, 2016
Effect of Two Lipoprotein (a)-Associated Genetic Variants on Plasminogen Levels and FibrinolysisHong Wang, Chan E Hong, Joshua P Lewis, et al.
Clinical Pharmacology and Therapeutics|June 21, 2020
Genetic Variation in PEAR1, Cardiovascular Outcomes and Effects of Aspirin in a Healthy Elderly PopulationJoshua P Lewis, Moeen Riaz, Sophia Xie, et al.
Journal of Clinical Lipidology|December 17, 2018
Increased usual physical activity is associated with a blunting of the triglyceride response to a high-fat mealBraxton D Mitchell, Gurmannat Kalra, Kathleen A Ryan, et al.
The Journal of Clinical Endocrinology and Metabolism|October 26, 2006
Association of alpha2-Heremans-Schmid glycoprotein polymorphisms with subclinical atherosclerosisAllison B Lehtinen, Kathryn P Burdon, Joshua P Lewis, et al.
G3 (Bethesda, Md.)|July 15, 2016
From Genotype to Phenotype: Nonsense Variants in SLC13A1 Are Associated with Decreased Serum Sulfate and Increased Serum AminotransferasesChristina G Tise, James A Perry, Leslie E Anforth, et al.
Journal of the American Heart Association|May 29, 2015
CYP2C19 metabolizer status and clopidogrel efficacy in the Secondary Prevention of Small Subcortical Strokes (SPS3) studyCaitrin W McDonough, Leslie A McClure, Braxton D Mitchell, et al.
Pharmacogenetics and Genomics|February 17, 2017
Genome-wide analysis of clopidogrel active metabolite levels identifies novel variants that influence antiplatelet responseJoshua D Backman, Jeffrey R O'Connell, Keith Tanner, et al.
Plos One|September 26, 2015
Genetic Variation in the Platelet Endothelial Aggregation Receptor 1 Gene Results in Endothelial DysfunctionAdam S Fisch, Laura M Yerges-Armstrong, Joshua D Backman, et al.
Journal of the American Heart Association|October 28, 2015
Oxylipid Profile of Low-Dose Aspirin Exposure: A Pharmacometabolomics StudySandrine Ellero-Simatos, Amber L Beitelshees, Joshua P Lewis, et al.
Pageof 6